E47 as a novel glucocorticoid-dependent gene mediating lipid metabolism in patients with endogenous glucocorticoid excess

E47 as a novel glucocorticoid-dependent gene mediating lipid metabolism in patients with endogenous glucocorticoid excess

PurposeE47 has been identified as a modulating transcription factor of glucocorticoid receptor target genes, its loss protecting mice from metabolic adverse effects of glucocorticoids. We aimed to analyze the role of E47 in patients with endogenous glucocorticoid excess [Cushing’s syndrome (CS)] and...

Full description

Bibliographic Details
Main Authors:	Wei Zhang, Hanna Nowotny, Marily Theodoropoulou, Julia Simon, Charlotte M. Hemmer, Martin Bidlingmaier, Matthias K. Auer, Martin Reincke, Henriette Uhlenhaut, Nicole Reisch
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Endocrinology
Subjects:	Cushing’s syndrome Cushing’s disease transcription factor 3 comorbidity dyslipidemia ACTH
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1249863/full

Similar Items

A case of cushing syndrome of undetermined cause managed medically with cabergoline
by: Muneer Ahmad, et al.
Published: (2018-12-01)

Metabolic complications of endogenous Cushing: patient selection for screening
Published: (2013-03-01)

Ectopic ACTH Syndrome – Experience with Etomidate
by: Chin Voon Tong, et al.
Published: (2017-04-01)

Cushing's syndrome as a paraneoplastic feature of renal cell carcinoma: A case report
by: Asaad Moradi, et al.
Published: (2023-09-01)

Clinical features and risk factors for postoperative recurrence in patients with Cushing's syndrome of different etiologies
by: Yunjia Cai, et al.
Published: (2024-02-01)

Steroidogenesis inhibitors in the treatment of nonoperative Cushing’s syndrome – a literature review
by: Magdalena Kamińska, et al.
Published: (2023-06-01)

Challenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome
by: Catherine D. Zhang, et al.
Published: (2024-04-01)

Metabolic disorders during endogenous Cushing’s syndrome: prevalence, associated factors, and outcome after remission
by: Chihaoui Melika, et al.
Published: (2023-01-01)

Finding the Culprit: Cushing Syndrome Secondary to Lung Carcinoid Tumor
by: Richard Vaca, MD, et al.
Published: (2025-01-01)

Metabolic profile differences in ACTH‐dependent and ACTH‐independent Cushing syndrome
by: Zhengyang Li, et al.
Published: (2022-03-01)

Expert Consensus on Bilateral Inferior Petrosal Sinus Sampling in the Diagnosis of Cushing′s Syndrome (2023)
by: Chinese Medical Association Rare Diseases Branch, Hypothalamic and Pituitary Disease Group of China Alliance of Rare Diseases (CARD), et al.
Published: (2023-07-01)

Challenges in diagnosis and treatment of cushing disease in a 12-year-old boy. Case report
by: Agim Gjikopulli, et al.
Published: (2025-02-01)

Cushing’s syndrome caused by ACTH precursors secreted from a pancreatic yolk sac tumor in an adult—a case report and literature review
by: Johnny Yau Cheung Chang, et al.
Published: (2023-12-01)

Psychotic symptoms in Cushing’s syndrome secondary to ACTH-secreting lung carcinoid tumor: report of a case
by: A. Llimona González, et al.
Published: (2022-06-01)

Editorial: Insights in Cushing’s syndrome and disease, volume II
by: Fabienne Langlois
Published: (2024-10-01)

Case report: Pheochromocytoma-induced pseudo-Cushing’s syndrome
by: Bobrowicz Małgorzata, et al.
Published: (2024-12-01)

HYPERPIGMENTATION AND ACTH – AN OVERVIEW OF LITERATURE
by: Florica Sandru, et al.
Published: (2019-12-01)

Cushing Syndrome Due to a Corticotropin-Releasing Hormone– and Adrenocorticotropic Hormone–Secreting Silent Pheochromocytoma
by: Sananda Moctezuma, MD, et al.
Published: (2024-05-01)

Intensity-modulated radiotherapy for cushing’s disease: single-center experience in 70 patients
by: Xin Lian, et al.
Published: (2023-09-01)

Cushing’s glucocorticoid syndrome in the practice of a rheumatologist (A review of literature)
by: Azamat Makhmudovich Satybaldyev
Published: (2013-12-01)

Delineating endogenous Cushing’s syndrome by GC-MS urinary steroid metabotypingResearch in context
by: Leah T. Braun, et al.
Published: (2024-01-01)

Editorial: Glucocorticoids and cognition: recent advances in understanding their interaction, with a particular focus on clinical applicability for the treating endocrinologist
by: Ian Louis Ross, et al.
Published: (2023-12-01)

ACTH-producing adrenocortical carcinoma: an exceedingly rare diagnosis
by: Miguel Saraiva, et al.
Published: (2024-07-01)

Efficacy and Safety of Levoketoconazole in Managing Cushing’s Syndrome: A Systematic Review
by: Shinjan Patra, et al.
Published: (2024-08-01)

Efficacy and Safety of Osilodrostat in Managing Cushing’s Syndrome: A Systematic Review and Meta-Analysis
by: Lakshmi Nagendra, et al.
Published: (2024-06-01)

Evaluating the usefulness of plasma chromogranin A measurement in cyclic ACTH-dependent Cushing’s syndrome
by: Keisuke Kakizawa, et al.
Published: (2024-10-01)

Cerebrospinal fluid rhinorrhea as a complication of ACTH-secreting pituitary macroadenoma in a patient with morbid obesity
by: Dar'ya Viktorovna Petrova, et al.
Published: (2014-12-01)

Performance of Vasopressin Stimulated Bilateral Inferior Petrosal Sinus Sampling in Corticotropin Dependent Cushing’s Syndrome with Negative or Equivocal 3 Tesla Contrast Enhanced Magnetic Resonance Imaging of Pituitary
by: Puneet Shivnani, et al.
Published: (2024-12-01)

Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey
by: M Cherenko, et al.
Published: (2024-05-01)

Exogenous Cushing Syndrome: When do We Get the Benefit of Glucocorticoid Stress Dose?
by: Soebagijo Adi Soelistijo, et al.
Published: (2020-09-01)

Accuracy of the 10 μg desmopressin test for differential diagnosis of Cushing syndrome: a systematic review and meta-analysis
by: Rodrigo Rosa Giampietro, et al.
Published: (2024-01-01)

Bilateral macronodular adrenocortical disease: a single centre experience
by: Anuj Ban, et al.
Published: (2025-02-01)

Pre- and Post-surgical Prevalence of Hyperglycemia in Patients with Subclinical Cushing's Syndrome Secondary to Adrenal Incidentaloma
by: ZHANG Zheng, ZHANG Wei, ZHANG Ying, DU Juan, ZOU Dajin
Published: (2024-05-01)

The AANS Harvey Cushing Medal: a demographic and academic analysis of its recipients
by: Kevin Pierre, et al.
Published: (2023-11-01)

Genome-wide Methyl-Seq analysis of blood-brain targets of glucocorticoid exposure
by: Fayaz Seifuddin, et al.
Published: (2017-08-01)

Retrospective study on trilostane titration dose treatment in dogs with terminal stage of hyperadrenocorticism
by: Irena Celeska, et al.
Published: (2024-03-01)

Patients with Cushing’s syndrome suffer from provoked venous thromboembolism and are anticoagulated in various patterns
by: Agata Hanna Bryk-Wiązania, et al.
Published: (2024-08-01)

Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing’s syndrome
by: Yasutaka Tsujimoto, et al.
Published: (2024-12-01)

Tümör Doku Heterojenitesinin 2DE Proteomik Yaklaşımıyla Gösterilmesi
by: Zafer Cantürk, et al.
Published: (2022-06-01)

Ketogenic Diet Initially Masks Symptoms of Hypercortisolism in Cushing’s Disease
by: Mary Kimberly Dugandzic, et al.
Published: (2022-10-01)